AUTH/1925/12/06: Novartis v ApoPharma (Ferriprox) — breach of undertaking and “Life is Getting Longer” hanging comparison

📅 2006 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/1925/12/06
PartiesNovartis Pharmaceuticals UK Ltd v ApoPharma Inc
ProductFerriprox (deferiprone)
Comparator mentionedDesferal (desferoxamine) supplied by Novartis
MediumAnimated banner advertisement on British Journal of Haematology website; linked landing page on Ferriprox.com; link-out to PubMed
Key claims at issue“Life is Getting Longer … in thalassaemia major patients”; “New Cardioprotection and Survival Data Now Available”
Core issueBreach of undertaking (re-use of previously ruled hanging comparison) and associated high standards/industry discredit findings; substantiation point on “data available” wording overturned on appeal
Applicable Code year2006
Complaint received30 November 2006 (HTML); 1 December 2006 (PDF)
Case completed18 April 2007 (HTML); 19 April 2007 (PDF)
Breach clauses (final)2, 7.2, 9.1 and 22
Clause 7.4No breach on appeal
SanctionsUndertaking received; Additional sanctions: Advertisement
Prior related caseAUTH/1822/4/06 (undertaking given; “Life is Getting Longer” previously ruled a hanging comparison)

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Novartis complained about an animated Ferriprox (deferiprone) banner ad on the British Journal of Haematology website.
  • The banner stated: “New Cardioprotection and Survival Data Now Available”.
  • A link (“For reference or prescribing information please click here”) took users to Ferriprox.com, where the landing page was headed: “Life is Getting Longer … in thalassaemia major patients”.
  • From that landing page, a further link took readers to PubMed for Borgna-Pignatti et al (2006).
  • Novartis alleged the “Life is Getting Longer …” headline was a hanging comparison (as previously ruled) and therefore a breach of an undertaking given in Case AUTH/1822/4/06.
  • Novartis also alleged the survival-related messaging was unsubstantiated/misrepresented by the cited paper.
  • Because this involved an alleged breach of undertaking, the Director took the matter up with ApoPharma (PMCPA responsibility to ensure compliance with undertakings).
  • ApoPharma said the “Life is Getting Longer” phrase had been removed from the UK banner in August 2006, but remained on the linked page due to oversight; it also argued the banner was a notification that data existed.
⚖️

Outcome

  • Panel: The reappearance of “Life is Getting Longer …” on the linked page was covered by the Code, was a hanging comparison, and breached the undertaking. Breaches ruled of Clauses 7.2, 22, 9.1 and 2.
  • Panel: Initially ruled a breach of Clause 7.4 in relation to “New Cardioprotection and Survival Data Now Available” (considered too strong/unsubstantiated given study limitations).
  • Appeal Board: Overturned the Clause 7.4 ruling—held the banner wording, as presented, was a statement of fact that data were available, not a claim of positive data. No breach of Clause 7.4.
  • The Clause 7.2, 22, 9.1 and 2 rulings were not appealed.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training